337 filings
Page 3 of 17
8-K
13ix9ssh44unpfkpr962
10 Aug 22
Pacira BioSciences Reports Preliminary Net Product Sales of $50.2 Million for July 2022
12:00am
S-8
44ze9f92nofe1p o8plf
4 Aug 22
Registration of securities for employees
4:39pm
8-K
r5w976c
3 Aug 22
Pacira BioSciences Reports Second Quarter 2022 Financial Results
8:02am
8-K
0d2183dsh2
14 Jul 22
Pacira BioSciences Reports Preliminary Second Quarter 2022 Revenue of $169.4 Million
7:53am
8-K
ab3p83f65hn890w ng
14 Jun 22
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $46.0 Million for May 2022
8:02am
8-K
re5p8i
10 Jun 22
Departure of Directors or Certain Officers
4:05pm
8-K
a1vtc5y0kgy
12 May 22
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $45.8 Million for April 2022
8:09am
8-K
ry18b fm8z9f2f0oxseb
4 May 22
Pacira BioSciences Reports First Quarter 2022 Financial Results
8:08am
DEFA14A
zo5ornxncqlmbq
22 Apr 22
Additional proxy soliciting materials
4:16pm
8-K
0awz9
12 Apr 22
Pacira BioSciences Reports Preliminary Revenues of $157.4 to $158.4 Million for the First Quarter of 2022
8:02am
8-K
ttuiftzvg hgfsh
15 Mar 22
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of
8:02am
8-K
lr337bu16eb678639
24 Feb 22
Pacira BioSciences Reports Full-Year and Fourth Quarter 2021 Financial Results
8:02am
8-K
a1iv8 wwg
15 Feb 22
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of
8:01am
8-K/A
m5xylrewnki5xakuu
7 Feb 22
Financial Statements and Exhibits
4:48pm
8-K
z2rphr34fr
6 Jan 22
Pacira Reports Preliminary Unaudited Total Revenue for 2021 of of $540.7 Million to $541.7 Million
8:03am
8-K
to2 bbr7ji0be60u
9 Dec 21
Pacira BioSciences Announces Closing of $375 Million Five-Year Term Loan B
8:15am